| Product NDC: | 49527-942 |
| Proprietary Name: | SUPER CITY BLOCK |
| Non Proprietary Name: | zinc oxide, octinoxate, titanium dioxide, and octisalate |
| Active Ingredient(s): | 7.5; 2; 6.6; 8.8 mL/100mL; mL/100mL; mL/100mL; mL/100mL & nbsp; zinc oxide, octinoxate, titanium dioxide, and octisalate |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | CREAM |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 49527-942 |
| Labeler Name: | CLINIQUE LABORATORIES INC. |
| Product Type: | HUMAN OTC DRUG |
| FDA Application Number: | part352 |
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Start Marketing Date: | 20040901 |
| Package NDC: | 49527-942-01 |
| Package Description: | 1 BOTTLE in 1 CARTON (49527-942-01) > 40 mL in 1 BOTTLE |
| NDC Code | 49527-942-01 |
| Proprietary Name | SUPER CITY BLOCK |
| Package Description | 1 BOTTLE in 1 CARTON (49527-942-01) > 40 mL in 1 BOTTLE |
| Product NDC | 49527-942 |
| Product Type Name | HUMAN OTC DRUG |
| Non Proprietary Name | zinc oxide, octinoxate, titanium dioxide, and octisalate |
| Dosage Form Name | CREAM |
| Route Name | TOPICAL |
| Start Marketing Date | 20040901 |
| Marketing Category Name | OTC MONOGRAPH NOT FINAL |
| Labeler Name | CLINIQUE LABORATORIES INC. |
| Substance Name | OCTINOXATE; OCTISALATE; TITANIUM DIOXIDE; ZINC OXIDE |
| Strength Number | 7.5; 2; 6.6; 8.8 |
| Strength Unit | mL/100mL; mL/100mL; mL/100mL; mL/100mL |
| Pharmaceutical Classes |